|
1
|
dos Santos ÉM, Ataide JA, Coco JC, Fava ALM, Silvério LAL, Sueiro AC, Silva JRA, Lopes AM, Paiva-Santos AC, Mazzola PG. Spondias sp: Shedding Light on Its Vast Pharmaceutical Potential. Molecules 2023; 28:molecules28041862. [PMID: 36838849 PMCID: PMC9963416 DOI: 10.3390/molecules28041862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 02/08/2023] [Accepted: 02/10/2023] [Indexed: 02/18/2023] Open
Abstract
Many plants are used by the population through popular knowledge passed from generation to generation for the treatment of various diseases. However, there is not always any scientific content supporting these uses, which is very important for safety. One of these plants is the fruit of the Spondias genus, which during its processing generates various residues that are discarded, but which also have pharmacological properties. The focus of this review is to survey the pharmacological activities that Spondias genus shows, as well as which part of the plant is used, since there is a lot of richness in its by-products, such as leaf, bark, resin, seed, and peel, which are discarded and could be reused. The main activities of this genus are antioxidant, anti-inflammatory, antidiabetic, antifungal, and antiviral, among others. These properties indicate that this genus could be used in the treatment of several diseases, but there are still not many products available on the market that use this genus as an active ingredient.
Collapse
Affiliation(s)
- Érica Mendes dos Santos
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| | - Janaína Artem Ataide
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
- Correspondence: (J.A.A.); (J.C.C.)
| | - Julia Cedran Coco
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
- Correspondence: (J.A.A.); (J.C.C.)
| | - Ana Laura Masquetti Fava
- School of Medical Sciences, University of Campinas (Unicamp), Rua Tessália Vieira de Camargo, 126, Campinas, São Paulo 13083-887, Brazil
| | - Luiza Aparecida Luna Silvério
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| | - Ana Claudia Sueiro
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| | - Jéssica Ribeiro Alves Silva
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| | - André Moreni Lopes
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| | - Ana Cláudia Paiva-Santos
- Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- LAQV, REQUIMTE, Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Azinhaga Sta. Comba, 3000-548 Coimbra, Portugal
| | - Priscila Gava Mazzola
- Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Rua Cândido Portinari, 200, Campinas, São Paulo 13083-871, Brazil
| |
Collapse
|